BEVERLY HILLS, Calif., April 13, 2012
BEVERLY HILLS, Calif., April 13, 2012 /PRNewswire/ --Â AATAC, AACSA, and SKYROCK retailers can expect to start seeing Clotamin appear in their locations for sale to the general public. A marketing and distribution agreement executed earlier this month with these groups allows retailers to participate in the resale of this product at various locations. Clotamin is anticipated to share premium counter top space alongside such products as 5-Hour Energy, Wrigley's Gum, Hershey's, and other industry specific names. Such influence over the retail industry has allowed companies to expose their product lines to over 1,000 customers a day in hard to reach areas.
Many convenience stores, small pharmacies, and ethnic grocery stores are located in areas that are highly neighborhood-centric. These are also the same areas that many popular and larger chains do not have a presence and makes it difficult for consumers in these areas to have easy access to breakthrough products such as Clotamin. Through this strategic deployment partnership, these associations look to be able to make this product available for the target consumer on a very local level. These combined locations touch 1 out of 3 Americans every single day. In 2011, 1 out of every 25 dollars spent nationwide was spent within these locations. This all adds up to giving companies and products a reach that was unobtainable in the past.
Clotamin is a product produced and distributed by Healthcare Distribution Specialists, LLC (HDS), a wholly owned subsidiary of Sunpeaks Ventures, Inc. who is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. ClotaminÂ®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on WarfarinÂ®, a popular blood thinner that has a long list of known adverse drug and food interactions. Sunpeaks Ventures also trades publicly under the OTCBB: SNPK ; PINKSHEETS: SNPK. For more information on Sunpeaks Ventures, Inc. visit them at www.sunpeaksventures.com.
"Early tracking and estimates show that Clotamin has the ability to be a breakout product in our retail channel and we look forward to seeing what this could mean in additional revenue to our retailers and added benefit for our consumers," said Paul Rock BOD TRUSTEE of AACSA PARTNERS and speaker for the AATAC council.
With the combined reach and anticipated growth of such products, the associations aim to take such products out to over 200,000 retail business locations across the USA.
"While many products are born and hatched in different industries, this is where they come to grow up and stretch their wings over the US population," stated Philipp Gruendler Vice President of SKYROCK Venture's corporate development program.
For more information, visit www.AATAC.co or call 888-662-7780.
SOURCE AATACPR Newswire
Last updated on: 13/04/2012